Lion’s mane mushroom (Hericium erinaceus), known in Japan as yamabushitake, is a long-standing culinary and traditional ingredient that has become one of the more talked-about “brain” ingredients abroad. Brands ask for it as a nootropic-style ingredient, often pointing to its long history of use in Japan as evidence of both safety and effect.
This guide is for brand owners planning an oral lion’s mane product made in Japan. It covers what the human trials actually show, the difference between fruiting body and mycelium material, and how to formulate the product.
Health supplements are foods, not medicines, and are not a substitute for medical treatment. Nothing here is a claim that any product prevents, treats or cures a disease.
💬 Planning a lion’s mane product made in Japan? We check the full formula against Japanese food law first. See Japan-made supplement OEM.
What the research shows
Small Japanese trials in older adults with mild cognitive difficulties found benefits from weeks of daily lion’s mane intake, while a 2025 trial in healthy younger adults found no effect from a single dose.
| Study | Design/What was analysed | Reported result |
|---|---|---|
| Double-blind, placebo-controlled trial, Phytother Res 2009 (PMID 18844328) | 30 Japanese adults aged 50-80 with mild cognitive impairment, given dried Hericium erinaceus powder (four 250 mg tablets, 96% mushroom powder, three times daily) or placebo for 16 weeks, with 4-week follow-up | Cognitive function scale scores rose significantly in the treatment group from week 8 onward compared with placebo, but fell significantly within 4 weeks of stopping intake; no adverse effects on laboratory tests |
| Randomised, double-blind, placebo-controlled trial, Biomed Res 2019 (PMID 31413233) | Adults given a supplement containing Hericium erinaceus fruiting body for 12 weeks, assessed with three separate cognitive tests (MMSE, Benton visual retention test, verbal paired-associate learning) | Only the MMSE test showed a significant improvement and prevention of decline; the other two tests did not reach significance |
| Randomised, double-blind, placebo-controlled crossover trial, Front Nutr 2025 (PMID 40276537) | 18 healthy adults aged 18-35, given a single 3 g acute dose of Hericium erinaceus fruiting body extract (10:1) or placebo, tested 90 minutes later | No significant effect on composite measures of global cognitive function or mood; one individual test (a psychomotor pegboard test) improved, but the authors describe any benefit as possibly task-specific rather than general |
All three trials are small. The two positive-leaning trials studied older adults with existing memory complaints or mild cognitive impairment over several weeks, not healthy adults after a single dose; the 2025 trial studied healthy younger adults after one dose and found no broad effect, and two of its authors were employed by a company that uses Hericium erinaceus in its products, a disclosed conflict of interest. The improvement seen in the 2009 trial faded within a month of stopping the supplement, which points to an effect tied to continued intake rather than a lasting change.
Checked against the published abstracts on 25 September 2026.
Fruiting body and mycelium are not interchangeable
Lion’s mane produces two different families of active compounds depending on which part of the mushroom is used, so a supplement’s raw material matters as much as its dose.
Hericenones are found mainly in the fruiting body (the mushroom itself), while erinacines are found mainly in the mycelium (the root-like growth medium). Both compound families have been studied for stimulating nerve growth factor synthesis in laboratory research, but through different chemical structures, and most of the human trials above used fruiting-body material specifically. A “lion’s mane” ingredient described only by species name, without stating whether it is fruiting body, mycelium or a blend, and without a compound-content specification, is not a fully defined material for formulation purposes.
What Japanese products say
Yamabushitake has a long history as an edible mushroom and general food ingredient in Japan, and the trials above were conducted by Japanese research groups, but this guide did not find a confirmed generic Foods with Function Claims notification for it.
Foods with Function Claims notifications in Japan are ingredient- and formula-specific, filed individually by the notifying business, so their existence for one product does not establish a generic functional claim for the ingredient as a category. Whether Japan can manufacture a lion’s mane product as a food depends on its long-standing status as a general food ingredient, not on a Foods with Function Claims notification, and a brand wanting to carry a specific functional claim in Japan would need its own qualifying evidence and notification.
💬 Need help thinking through what your lion’s mane product can and cannot claim in Japan and your other markets? Tell us your market and we work through it with the manufacturing documents.
Wording that stays on safe ground
Describe lion’s mane by what has actually been studied — weeks of intake in adults with existing memory complaints — not as a general nootropic guarantee.
| Safer wording | Wording to avoid |
|---|---|
| ”Studied for cognitive performance with continued daily intake" | "Instantly boosts brainpower” or similar acute/one-dose claims |
| Stating whether the material is fruiting body, mycelium or a blend | An unspecified “lion’s mane extract” with no compound-content detail |
| ”Contains Hericium erinaceus” with the amount per serving | Naming any disease or cognitive disorder |
How lion’s mane is formulated
Lion’s mane is typically supplied as a dried powder or standardised extract, which fits most common dosage forms.
| Dosage form | Why brands choose it | What to weigh up |
|---|---|---|
| Hard capsule | Simple, masks the mushroom’s taste | Fill weight needed for gram-level doses used in trials |
| Tablet | Familiar, precise dosing | May need a large tablet size for higher doses |
| Powder or drink mix | Suits higher doses, e.g. 3 g servings seen in trials | Taste and solubility of the mushroom powder or extract |
Decisions that shape the specification:
- Fruiting body vs mycelium vs blend. Specify which part of the mushroom the material comes from, since this affects which compound family is present and how it compares to the studies above.
- Extract standardisation. Ask the supplier for beta-glucan content or another standardised marker, and whether the material is a simple dried powder or a concentrated extract.
- Amount per serving. Match the amount to a study you intend to cite; the trials above used substantially different daily amounts.
- Companion ingredients. Lion’s mane is often combined with other brain-focus ingredients. Every ingredient in such a formula needs its own check against Japanese food law.
- Your market’s status for lion’s mane. Confirm its status as a food or novel-food ingredient in each market you plan to sell in.
The check that comes first
Every ingredient must be permitted in foods in Japan, or a Japanese factory cannot make the product.
Yamabushitake is a widely eaten mushroom in Japan, so companion herbs and extract standardisation are usually where a formula needs the closest attention. See the Japan-made supplement OEM page, and compare with our ginkgo biloba and PQQ guides for other brain-focus ingredients.
Before you ask for a quotation
A factory can quote accurately once the material, the amount, the form, the companions and the packaging are fixed.
- Fruiting body, mycelium, or a blend, and any standardisation marker
- Lion’s mane amount per serving and servings per pack
- Dosage form and any companion ingredients
- Packaging
- Countries you will sell in, and lion’s mane’s status there
- First order and annual volume
💬 Ready to design a Japan-made lion’s mane product? Send us the concept — material type, amount, form, companion ingredients and the countries you will sell in.
Frequently asked questions
1. Does lion’s mane improve memory and cognitive function?
The evidence is preliminary. Small Japanese trials over 12-16 weeks in older adults with mild cognitive impairment found benefits on some but not all measures used, while a 2025 trial found no effect from a single dose in healthy younger adults. Describe lion’s mane as studied for cognitive performance with continued intake, not as a proven cognitive enhancer.
2. Is fruiting body or mycelium better?
They contain different active-compound families — hericenones mainly in the fruiting body, erinacines mainly in the mycelium — and most human trials to date used fruiting-body material. Neither has been shown in human trials to be clearly superior; specify which one your material uses.
3. Does the effect last after stopping the supplement?
In the one trial that measured this, cognitive scores fell significantly within four weeks of stopping the 16-week course, suggesting any benefit depends on continued intake rather than being a lasting change.
4. Does Japan have a functional claim for lion’s mane?
This guide did not find a confirmed generic Foods with Function Claims notification for lion’s mane. Any specific functional claim would need its own qualifying evidence and Japanese notification by the notifying business.
5. Which dosage form suits lion’s mane best?
Hard capsules and tablets are common for standardised extracts; powder or drink formats suit the higher gram-level doses seen in some trials.
Sources: “Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial”, Phytother Res 2009, PMID 18844328; “Improvement of cognitive functions by oral intake of Hericium erinaceus”, Biomed Res 2019, PMID 31413233; “Acute effects of a standardised extract of Hericium erinaceus (Lion’s Mane mushroom) on cognition and mood in healthy younger adults”, Front Nutr 2025, PMID 40276537. Checked on 25 September 2026.